Ly-Ann Teo-Fortin
Papers
4
Total Citations
32
H-Index
3
About
Dr. Ly-Ann Teo-Fortin is a leading Canadian gynecologic oncologist whose research focuses on optimizing surgical approaches for early-stage cervical cancer, particularly the critical balance between oncologic safety and minimally invasive techniques. As a core member of the Canadian Cervical Cancer Collaborative (4C), she has spearheaded landmark multicenter studies that directly challenge and refine surgical dogma. Her most cited work, a 2022 study comparing abdominal, minimally invasive, and combined vaginal-laparoscopic hysterectomy for stage IA1/IA2 cervical cancer (15 citations), provides essential comparative effectiveness data. Dr. Teo-Fortin’s subsequent investigations into oncologic outcomes for patients with no residual disease after hysterectomy and the impact of surgical approach on margin status (each with 7 citations) have been instrumental in clarifying how preoperative conization may mitigate risks associated with minimally invasive surgery. Her 2024 study on the safety of vaginal surgery further expands the evidence base for less invasive options. With a cumulative impact of over 30 citations in just three years, Dr. Teo-Fortin’s work is shaping national practice guidelines and offering surgeons and patients clearer, evidence-based pathways for managing early-stage cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4